BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14626982)

  • 21. Commercial speech law and tobacco marketing: a comparative discussion of the United States and Canada.
    Berman ML
    Am J Law Med; 2013; 39(2-3):218-36. PubMed ID: 23815029
    [No Abstract]   [Full Text] [Related]  

  • 22. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.
    Javitt GH; Stanley E; Hudson K
    Oklahoma Law Rev; 2004; 57(2):251-302. PubMed ID: 15658034
    [No Abstract]   [Full Text] [Related]  

  • 23. Public Health and the First Amendment.
    Sharfstein JM
    Milbank Q; 2015 Sep; 93(3):459-62. PubMed ID: 26350923
    [No Abstract]   [Full Text] [Related]  

  • 24. FDA proposes mechanism for disseminating information about off-label uses.
    Am J Health Syst Pharm; 1998 Jul; 55(14):1449-50. PubMed ID: 9676288
    [No Abstract]   [Full Text] [Related]  

  • 25. Regulating drug promotion on the Internet.
    Bannon L
    Food Drug Law J; 1999; 54(4):599-621. PubMed ID: 11824457
    [No Abstract]   [Full Text] [Related]  

  • 26. The new drug marketing: a consumer protection perspective.
    Woodward D
    Food Drug Law J; 1996; 51(4):637-50. PubMed ID: 11797733
    [No Abstract]   [Full Text] [Related]  

  • 27. New challenges for medical product promotion and its regulation.
    Pines WL
    Food Drug Law J; 1997; 52(1):61-5. PubMed ID: 10346710
    [No Abstract]   [Full Text] [Related]  

  • 28. The Dietary Supplement Health and Education Act.
    Young AL; Bass IS
    Food Drug Law J; 1995; 50(2):285-92. PubMed ID: 10342995
    [No Abstract]   [Full Text] [Related]  

  • 29. Understanding government regulation of the marketing and advertising of medical devices, drugs, and biologics: the challenges of the Internet.
    Reichertz PS
    Food Drug Law J; 1997; 52(3):303-8. PubMed ID: 10343029
    [No Abstract]   [Full Text] [Related]  

  • 30. Ambiguities of the Dietary Supplement Health and Education Act of 1994.
    Pinco RG; Rubin PD
    Food Drug Law J; 1996; 51(3):383-405. PubMed ID: 11797716
    [No Abstract]   [Full Text] [Related]  

  • 31. The WLF case thus far: not with a bang, but a whimper.
    Cooper RM
    Food Drug Law J; 2000; 55(4):477-89. PubMed ID: 12025847
    [No Abstract]   [Full Text] [Related]  

  • 32. The butt stops here: the Tobacco Control Act's anti-smoking regulations run afoul of the First Amendment.
    Weatherby D; Day TR
    Albany Law Rev; 2012-2013; 76(1):121-65. PubMed ID: 23577376
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmaceutical industry restructuring and new marketing approaches: enforcement responses.
    Mahinka SP; Sanzo KM
    Food Drug Law J; 1995; 50(2):313-25. PubMed ID: 10343000
    [No Abstract]   [Full Text] [Related]  

  • 34. The ongoing dialogue between the Food and Drug Administration and the Federal Trade Commission.
    Leary TB
    Food Drug Law J; 2004; 59(2):209-15. PubMed ID: 15318392
    [No Abstract]   [Full Text] [Related]  

  • 35. The First Amendment and federal court deference to the Food and Drug Administration: The Times They Are A-Changin'.
    Basile EM; Gross M
    Food Drug Law J; 2004; 59(1):31-44. PubMed ID: 15190924
    [No Abstract]   [Full Text] [Related]  

  • 36. Patient solicitation and the First Amendment. Protection of 'commercial speech' at issue in court cases.
    Sfikas PM
    J Am Dent Assoc; 2001 Apr; 132(4):532-4. PubMed ID: 11315383
    [No Abstract]   [Full Text] [Related]  

  • 37. Not as easy as it may appear: using radio frequency identification technology to fulfill the Prescription Drug Marketing Act's elusive pedigree requirement.
    Asamoah AK
    Food Drug Law J; 2006; 61(2):385-418. PubMed ID: 16903035
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug manufacturers' First Amendment right to advertise and promote their products for off-label use: avoiding a pyrrhic victory.
    Blackwell AE; Beck JM;
    Food Drug Law J; 2003; 58(3):439-62. PubMed ID: 14626985
    [No Abstract]   [Full Text] [Related]  

  • 39. FDA drops legal battle to introduce graphic pictures on cigarette packs.
    Davies E
    BMJ; 2013 Mar; 346():f1913. PubMed ID: 23526043
    [No Abstract]   [Full Text] [Related]  

  • 40. Education or promotion?: Industry-sponsored continuing medical education (CME) as a center for the core/commercial speech debate.
    Chen P;
    Food Drug Law J; 2003; 58(3):473-509. PubMed ID: 14626981
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.